✨ Your Portfolio is fetched and updated from zerodha.
Small Pharmaceuticals

SMS Pharmaceuticals Ltd.

SMSPHARMA

Market Cap
₹2,129 Cr.
P/E
32.20

SMS Pharmaceuticals Ltd.

  • SMS Pharmaceuticals
  • Bajaj Healthcare
  • IOL Chem & Pharma
  • TJI Pharma - Small Cap
FAQs on SMS Pharmaceuticals Ltd. Shareprice

SMS Pharmaceuticals has given lower returns compared to its competitors.
SMS Pharmaceuticals has grown at ~25.6% over the last 6yrs while peers have grown at a median rate of 29.85%

Yes, SMS Pharmaceuticals is expensive.
Latest PE of SMS Pharmaceuticals is 32.2, while 3 year average PE is 23.98.
Also latest EV/EBITDA of SMS Pharmaceuticals is 18.25 while 3yr average is 17.23.

View FAQ's On Business
Growth Table
  • SMS Pharmaceuticals Ltd.
  • Bajaj Healthcare
  • IOL Chem & Pharma
Balance Sheet
  • SMS Pharmaceuticals Ltd.
  • Bajaj Healthcare
  • IOL Chem & Pharma
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • SMS Pharmaceuticals Ltd.
  • Bajaj Healthcare
  • IOL Chem & Pharma
Cash Flow
  • SMS Pharmaceuticals Ltd.
  • Bajaj Healthcare
  • IOL Chem & Pharma
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • SMS Pharmaceuticals Ltd.
  • Bajaj Healthcare
  • IOL Chem & Pharma
Quarterly Results
  • SMS Pharmaceuticals Ltd.
  • Bajaj Healthcare
  • IOL Chem & Pharma
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Rhapson method.
Learn how to use Reverse DCF
FAQs on SMS Pharmaceuticals Ltd. Financials

Balance sheet of SMS Pharmaceuticals is strong.
But short term working capital might become an issue for this company.

Yes, The debt of SMS Pharmaceuticals is increasing.
Latest debt of SMS Pharmaceuticals is ₹276 Crs as of Sep-24.
This is greater than Mar-24 when it was ₹208 Crs.

Yes, profit is increasing.
The profit of SMS Pharmaceuticals is ₹63.37 Crs for TTM, ₹49.83 Crs for Mar 2024 and -₹7.06 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
SMS Pharmaceuticals latest dividend payout ratio is 6.8% and 3yr average dividend payout ratio is 5.44%

Companies resources are allocated to majorly unproductive assets like Accounts Receivable

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech